Israeli HMO adopts ACR imaging criteria

Article

Maccabi Health Care Services, the second largest HMO in Israel, saw utilization of CT and MR decrease after it implemented American College of Radiology appropriateness criteria in 2002.

Maccabi Health Care Services, the second largest HMO in Israel, saw utilization of CT and MR decrease after it implemented American College of Radiology appropriateness criteria in 2002.

CT use dropped 33% and MR use fell 8.7% in the 23 months after preauthorization requirements were instituted for the two modalities, Dr. Arve Blacher said at the 2004 RSNA meeting. Costs associated with the two procedures represented 1.4% of the provider's healthcare budget.

Referring physicians must phone in MR and CT requests to a central site for authorization. The call center staff responds with either an immediate authorization or a deferral followed by a written explanation.

A phone discussion with a radiologist to explain the decision is available on demand. In disputed cases, the referring physician may still order CT, but MR imaging may not be performed until after the disposition of an appeal.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.